Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase 3 2Phase NA 1Phase 1/2 1

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2

Conditions

Keratosis, Actinic 7Cholangiocarcinoma 3Carcinoma, Basal Cell 2Warts 1Neoplasms 1Gallbladder Neoplasms 1Carcinoma, Squamous Cell 1Bowen's Disease 1Bile Duct Neoplasms 1

Interventions

Imiquimod 4methyl 5-aminolevulinate 3Photochemotherapy 2Tretinoin 1Surgical Procedures, Operative 1Niacinamide 1Fluorouracil 1Electroporation 1Eflornithine 1Calcium Chloride 1BF-200 ALA 1Aminolevulinic Acid 11-phenyl-3,3-dimethyltriazene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Carcinoma, Basal Cell × Photochemotherapy × Clear all
NCT00472459 2025-04-18

Photodynamic Therapy (PDT) With Metvix® 160 Milligrams/Gram Cream in Organ Transplant Participants With Non-melanoma Skin Cancer

Galderma R&D

Phase 3 Completed
82 enrolled 20 charts
Dermatologic

Bowen's Disease, Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Warts, Keratosis, Actinic

NCT00472108 2024-08-05

Photodynamic Therapy (PDT) With Metvix Cream 160 mg/g Versus PDT With Placebo Cream in Participants With Primary Nodular Basal Cell Carcinoma

Galderma R&D

Phase 3 Completed
65 enrolled 15 charts
Dermatologic

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡